Working… Menu

Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02761174
Recruitment Status : Completed
First Posted : May 4, 2016
Last Update Posted : January 5, 2018
Skinperium, Christine Dierickx
Ellipse A/S Agern Allé 11, 2970 Hørsholm
Information provided by (Responsible Party):
Merete Haedersdal, Bispebjerg Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 11, 2016
Actual Study Completion Date : January 13, 2017